7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

ABVC Biopharma Inc
(NASDAQ:ABVC) 

ABVC stock logo

American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, a combination therapy for triple negative breast cancer; ABV-1504 for major depressive dis...

Founded: 2015
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
ABVC Biopharma Days Payable Outstanding ttm (DPO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -70.88-41.74-12.5916.5645.7174.85104133.15
ABVC Biopharma Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0540.71,081.411,622.112,162.812,703.523,244.223,784.92
ABVC Biopharma Days Inventory Outstanding ttm (DIO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1,287.61-1,018.99-750.37-481.75-213.1355.5324.12592.74
ABVC Biopharma Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -10.19-8.74-7.28-5.82-4.37-2.91-1.460
ABVC Biopharma Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -10.21-8.75-7.29-5.83-4.37-2.92-1.460
ABVC Biopharma Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.080.150.230.30.380.460.53
ABVC Biopharma P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 012.5725.1437.7150.2862.8575.4287.99
ABVC Biopharma (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -8.8-7.54-6.29-5.03-3.77-2.51-1.260
ABVC Biopharma P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.176.7514.6722.5830.538.4246.3354.25
No extra charts and metrics for this ticker.